01134.HK
Kelfred Holdings Limited
HKSE · Healthcare · Medical - Instruments & Supplies · HK
HKD 0.19
−10.38%Year over year
Reported trailing growth
- Revenue
- -4.3%
- EBITDA
- —
- EBIT
- —
- EPS
- -58.5%
- Free cash flow
- -76.4%
- Operating cash flow
- -67.6%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +2.4%
- EBITDA
- -42.3%
- EBIT
- +43.0%
- Net income
- +30.1%
- EPS
- +30.3%
- Free cash flow
- +16.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026